UK markets close in 8 hours 7 minutes

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (I54.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.92500.0000 (0.00%)
As of 03:29PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-382,951
-382,951
-601,945
-545,576
-428,091
Depreciation & amortisation
182,445
182,445
174,099
128,097
43,367
Stock-based compensation
30,975
30,975
15,313
27,752
132,453
Change in working capital
-9,238
-9,238
95,648
-10,178
-29,237
Inventory
3,455
3,455
-10,844
-34,437
-7,779
Other working capital
-203,264
-203,264
-543,537
-564,446
-531,733
Other non-cash items
85,236
85,236
52,216
29,613
3,326
Net cash provided by operating activities
-76,646
-76,646
-303,266
-365,778
-225,313
Cash flows from investing activities
Investments in property, plant and equipment
-126,618
-126,618
-240,271
-198,668
-306,420
Acquisitions, net
0
0
-7,257
0
-
Purchases of investments
0
0
-9,309
-540,000
-1,275,000
Sales/maturities of investments
0
0
101,464
649,780
1,393,195
Net cash used for investing activities
-100,278
-100,278
-153,738
-84,131
-188,180
Net change in cash
-214,743
-214,743
130,196
-230,469
454,949
Cash at beginning of period
610,882
610,882
466,445
697,294
246,384
Cash at end of period
399,607
399,607
610,882
466,445
697,294
Free cash flow
Operating cash flow
-76,646
-76,646
-303,266
-365,778
-225,313
Capital expenditure
-126,618
-126,618
-240,271
-198,668
-306,420
Free cash flow
-203,264
-203,264
-543,537
-564,446
-531,733